Q4 2025 Adapthealth Corp Earnings Call Transcript
Key Points
- AdaptHealth Corp (AHCO) achieved full-year revenue of $3.245 billion and Q4 revenue of $846.3 million, both exceeding the midpoint of their guidance range.
- The company set patient census records in Sleep Health, Respiratory Health, and Wellness at Home, with significant growth in new starts across these segments.
- AdaptHealth Corp (AHCO) successfully reduced its debt balance by $250 million in 2025, leading to credit rating upgrades from S&P and Moody's.
- The company operationalized new CMS documentation requirements for vents, potentially providing a competitive advantage in 2026.
- AdaptHealth Corp (AHCO) closed the acquisition of a Hawaii-based HME provider, expanding its footprint to 48 states and supporting its new capitated contract.
- Net revenue for the full year decreased by 0.5% compared to the prior year, impacted by dispositions.
- Diabetes Health net revenue declined by 7.4% in Q4 due to a shift in payer mix from commercial insurance to government payers, resulting in lower reimbursement per patient.
- The company incurred a $14.5 million legal settlement and over $10 million in accelerated costs related to new capitated arrangements, impacting profitability.
- A noncash goodwill impairment charge of $128 million was recognized in the Diabetes Health segment, reflecting challenges in that area.
- Free cash flow guidance for 2026 indicates potential negative cash flow in Q1 due to infrastructure investments for the new capitated contract.
Good day, everyone, and welcome to today's AdaptHealth fourth-quarter 2025 earnings release. Today's speakers will be Suzanne Foster, Chief Executive Officer of AdaptHealth; and Jason Clemens, Chief Financial Officer of AdaptHealth.
Before we begin, I would like to remind everyone that statements included in this conference call and in the press release issued today may constitute forward-looking statements within the meaning of Private Securities Litigation Reform Act. These statements include, but are not limited to, comments regarding financial results for 2025 and beyond. Actual results could differ materially from those projected in forward-looking statements .
Because of a number of risk factors and uncertainties, which are discussed at length in the company's annual and quarterly SEC filings, AdaptHealth Corp has no obligation to update the information provided on this call to reflect such subsequent events.
Additionally, on this morning's call, the company will reference certain financial measures such as EBITDA, adjusted EBITDA, adjusted EBITDA margin, and free cash
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
